The glucose monitor you keep
The glucose monitor you keep
The glucose monitor you keep
MOGLU®
MOGLU®
MOGLU®
Wearable concept · In development
Glucose, measured with light.
No needles. No adhesive patches. No disposable sensors to replace.
Powered by Raman spectroscopy.
Glucose, measured with light.
No needles. No adhesive patches. No disposable sensors to replace.
Powered by Raman spectroscopy.
Glucose, measured
with light.
No needles. No adhesive patches.
No disposable sensors to replace.
Powered by Raman spectroscopy.
We’re not just
removing the needle.
We’re not just
removing the needle.
We’re not just
removing the needle.
We’re removing the replacement cycle.
We’re removing the replacement cycle.
We’re removing the replacement cycle.
We’re removing the replacement cycle.
The signal is real.
Current phone-size prototype
Prototype Specifications: 80x90x30mm
Current phone-size prototype
Prototype Specifications: 80x90x30mm
11.34% MARD, measured side by side
Six participants wore Moglu alongside two commercial CGMs in the same sessions. Moglu 's accuracy fell between the two, with the narrowest spread of the three.
11.34% MARD, measured side by side
Six participants wore Moglu alongside two commercial CGMs in the same sessions. Moglu 's accuracy fell between the two, with the narrowest spread of the three.
100% in Parkes Zones A and B
Of 279 paired readings, 82% fell in Zone A and the rest in Zone B. None fell in zones linked to clinical risk.
100% in Parkes Zones A and B
Of 279 paired readings, 82% fell in Zone A and the rest in Zone B. None fell in zones linked to clinical risk.
The signal is real.
Current phone-size prototype
Prototype Specifications: 80x90x30mm
11.34% MARD, measured side by side
Six participants wore Moglu alongside two commercial CGMs in the same sessions. Moglu 's accuracy fell between the two, with the narrowest spread of the three.
100% in Parkes Zones A and B
Of 279 paired readings, 82% fell in Zone A and the rest in Zone B. None fell in zones linked to clinical risk.
The signal is real.
11.34% MARD, measured
side by side
Six participants wore Moglu alongside two commercial CGMs in the same sessions.
Moglu 's accuracy fell between the two, with the narrowest spread of the three.
100% in Parkes Zones A and B
Of 279 paired readings, 82% fell in Zone A and the rest in Zone B.
None fell in zones linked to clinical risk.
Current phone-size prototype
Prototype Specifications: 80x90x30mm
Our Team
Our team
Our Team
We build needle-free continuous glucose monitors powered by Raman spectroscopy. Our teams in Boston and Seoul blend deep expertise in optics, engineering, and healthcare to deliver precision solutions for diabetes care.
Aram Hong
CEO & Co-founder
Aram Hong
CEO & Co-founder
Miyeon Jue, PhD
CTO & Co-founder
Miyeon Jue, PhD
CTO & Co-founder
Advisors & Research Collaborators
Advisors & Research Collaborators
Advisors & Research Collaborators
Advisors & Research Collaborators
Medha Munshi, MD
Medha Munshi, MD
Director of the Joslin
Geriatric Diabetes Program
and a Professor of Medicine
at Harvard Medical School
Director of the Joslin
Geriatric Diabetes Program and a Professor of Medicine at Harvard Medical School
Medha Munshi, MD
Director of the Joslin
Geriatric Diabetes Program
and a Professor of Medicine
at Harvard Medical School
Medha Munshi, MD
Director of the Joslin
Geriatric Diabetes Program
and a Professor of Medicine
at Harvard Medical School
Laurence Alberts, MBA
Laurence Alberts, MBA
Co-founder & CEO,
Qlibrium; former Partner
& Managing Director, BCG
Co-founder & CEO,
Qlibrium; former Partner & Managing Director, BCG
Laurence Alberts, MBA
Co-founder & CEO,
Qlibrium; former Partner
& Managing Director, BCG
Laurence Alberts, MBA
Co-founder & CEO,
Qlibrium; former Partner
& Managing Director, BCG
Peter So, PhD
Peter So, PhD
Professor of Mechanical
Engineering and Biological
Engineeringat MIT
Professor of Mechanical
Engineering and Biological Engineeringat MIT
Peter So, PhD
Professor of Mechanical
Engineering and Biological
Engineeringat MIT
Peter So, PhD
Professor of Mechanical
Engineering and Biological
Engineeringat MIT
Jeon Woong Kang, PhD
Jeon Woong Kang, PhD
Research Scientist
at MIT Laser Biomedical
Research Center
Research Scientist
at MIT Laser Biomedical
Research Center
Jeon Woong Kang, PhD
Research Scientist
at MIT Laser Biomedical
Research Center
Jeon Woong Kang, PhD
Research Scientist
at MIT Laser Biomedical
Research Center
Jun Ki Kim, PhD
Jun Ki Kim, PhD
Co-founder & Associate
Professor at Asan Medical
Center
Co-founder & Associate Professor at Asan Medical Center
Jun Ki Kim, PhD
Co-founder & Associate
Professor at Asan Medical
Center
Jun Ki Kim, PhD
Co-founder & Associate
Professor at Asan Medical
Center
Help bring needle-free CGM
to the wrist.
Help bring needle-free CGM
to the wrist.
Help bring needle-free CGM to the wrist.
Investors
Investors
Investors
Investors
Programs & Recognition
Programs & Recognition
Programs & Recognition
Programs & Recognition
In the Press
In the Press
In the Press
In the Press
Company Updates
Company Updates
Company Updates
Company Updates
Investigational device. Not FDA cleared or available for sale.
Investigational device. Not FDA cleared or available for sale.
Investigational device.
Not FDA cleared or available for sale.